Dry Eye Syndrome Công cụ chẩn đoán

Cập nhật: 22 May 2025

Nội dung của trang này:

Nội dung của trang này:

Laboratory Tests and Ancillaries

Various diagnostic tests are useful in confirming the diagnosis but would often correlate poorly with symptoms. These tests can evaluate tear film instability, ocular surface damage, and aqueous tear flow.  

Fluorescein Dye Disappearance Test or Tear Function Index  

The fluorescein dye disappearance test or tear function index is used to assess the clearance or turnover of tears on the ocular surface. This test evaluates aqueous tear production, tear volume, and tear drainage. Findings in this test are more correlated with the severity of ocular irritation symptoms and corneal fluorescein staining than the Schirmer test. Delayed clearance is associated with high tear cytokine concentration which may contribute to chronic inflammation.  

Lacrimal Gland Function Test  

The lacrimal gland function test measures lactoferrin, the most abundant tear protein being secreted by the lacrimal gland. There is low lactoferrin concentration in patients with Sjögren syndrome and other causes of lacrimal gland dysfunction.  

Matrix Metalloproteinase-9 (MMP-9) Test  

The MMP-9 test may be used to assess the presence of inflammation and changes in disease states which may aid in the management.  

Ocular Surface Dye Staining  

Ocular surface dye staining evaluates the ocular surface by using dyes such as fluorescein dye, rose bengal, or lissamine green dyes. The degree oof conjunctival staining is indicative of the severity of dry eye syndrome.  

In the case of fluorescein dye, it stains areas of the corneal and conjunctival epithelia with disrupted intercellular junctions that are adequate to allow the dye to penetrate into the tissue. The presence of blotchy or exposure-zone punctate staining is consistent with DES. While mild staining may be seen in normal eyes especially in the morning. Rose bengal stains the ocular surface cells that are deficient in mucous coating and debris in the tear film. This stain may detect involvement of the conjunctiva by staining cells in the interpalpebral zone. Lastly, lissamine green stains similar to that of rose bengal but is well tolerated as fluorescein dye. It is not used in evaluating corneal epithelial disease.  

In cases of viral keratoconjunctivitis and medicamentosa, ocular surface dye staining shows diffuse staining of the cornea and conjunctiva. Staphylococcal blepharitis, meibomian gland dysfunction, or lagophthalmos would show staining on the inferior cornea and bulbar conjunctiva. In the case of superior limbic keratoconjunctivitis, there is staining on the superior bulbar conjunctiva. Staining on the interpalpebral cornea and bulbar conjunctiva is usually observed in aqueous tear deficiency.  

Schirmer Test  

Schirmer test is used to assess aqueous tear production or flow. It is performed by placing a narrow filter paper strip in the inferior cul-de-sac and measuring the length of the strip wets during the period of 5 minutes. This test may be done with or without anesthesia to measure the reflex tearing or with anesthesia to measure basal tearing by minimizing ocular surface reflex activity. Schirmer test with anesthesia is considered abnormal if the result is ≤10 millimeters after 2 minutes. It must be remembered that an isolated abnormal result may be nonspecific but a consistently low result is highly suggestive of aqueous tear deficiency. However, given that results of the Schirmer test are usually variable, it should not be used as the sole criterion to diagnose DES.  

Tear Film Break-up Time (TFBUT) test  

The TFBUT test measures the lapsed time between the last blink and the appearance of the first break in the fluorescein-stained tear film. It is used to evaluate tear film instability. The presence of a localized anterior basement membrane abnormality may be considered if the tear break-up time in the same area is recurrent. An abnormal result is considered when TFBUT is <10 seconds which may be seen in both aqueous tear deficiency and meibomian gland disease.  

Tear Osmolarity Test  

The tear osmolarity test has been shown to be more sensitive and specific in diagnosing and grading the severity of DES as compared to corneal and conjunctival staining, TFBUT, Schirmer test, and meibomian gland grading.  

Other Tests  

Videokeratography may be used to objectively diagnose and evaluate the severity of DES, screen patients prior to LASIK, and identify their post-LASIK chronic DES risk. Another test that can be done is impression cytology. Impression cytology is a less invasive alternative to ocular biopsy that is used to determine abnormalities like goblet cell loss and squamous metaplasia.  

Specific Tests in Patients with Underlying Conditions  

Antibodies such as anti-Rho (SSA), anti-La (SSB), anti-nuclear antibody (ANA), and rheumatoid factor are detected for Sjögren syndrome. Additional biomarkers such as salivary protein 1 (SP1), carbonic anhydrase 6 (CA6), and parotid secretory protein (PSP) may be used to determine early Sjögren syndrome or other forms of autoimmune DES.  

Antithyroid peroxidase antibody, antithyroglobulin antibody, and orbital imaging such as computed tomography (CT) and magnetic resonance imaging (MRI) scan can be done to assess for thyroid disease. MRI is especially helpful in assessing extraocular muscle thickness. Serum lysozyme, ACE test, chest CT scan (to determine the extent of disease) and conjunctival biopsy can be done in patients with sarcoidosis. Lastly, conjunctival biopsy with light microscopy, immunofluorescent or immunohistochemical studies are done for those with ocular mucous membrane pemphigoid.